Last ¥5,461 JPY
Change Today +120.00 / 2.25%
Volume 2.1M
6988 On Other Exchanges
As of 2:00 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

nitto denko corp (6988) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/29/14 - ¥6,084
52 Week Low
12/13/13 - ¥4,040
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NITTO DENKO CORP (6988)

Related News

No related news articles were found.

nitto denko corp (6988) Related Businessweek News

No Related Businessweek News Found

nitto denko corp (6988) Details

Nitto Denko Corporation primarily engages in the adhesive tapes business in Japan and internationally. It provides double sided tapes, surface protective films, sealing materials/NVH related products, masking tapes, membranes, FPD/touch panel related products, gasket materials, semiconductor manufacturing process products, flexible printed circuit boards, porous films/breathable materials, and packaging tapes. The company also offers functional thermal transfer systems, such as labels, barcode label printers, and label printing software; tapes for electrical and electronic equipment; dust removal products for clean rooms; fluoroplastic sheets and tapes, and fluoroplastic porous films; and materials for housing and construction, as well as packaging machines. In addition, it provides medical products, including transdermal drug delivery patches, medical surgical products/supportive items, athletic tapes, medical surgical products/adhesive plasters sheets, adhesive tapes, and particles for nucleic acid synthesis. The company offers its products to transportation, house/house equipment, infrastructure, material, home appliance and electrical, display, electronic device, medical, packing product/packing machine, and consumer/personal care industries. Nitto Denko Corporation was founded in 1918 and is headquartered in Osaka, Japan.

26,614 Employees
Last Reported Date: 06/20/14
Founded in 1918

nitto denko corp (6988) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nitto denko corp (6988) Key Developments

Nitto Denko Corporation Announces Anti-Fibrosis Drug with Molecular Targeting DDS Starts Phase-1B Dosing for Cirrhosis Patients

Nitto Denko Corporation announced the initiation of a phase-1b clinical study in the US started on September 2014, to administer a new anti-fibrosis drug in patients for the assessment of safety and efficacy. Nitto has been developing an RNAi based drug for treating fibrosis in the liver and other organs since 2008 in collaboration with Sapporo Medical University and Hokkaido University. In March 2014, a Phase-1 clinical study in healthy volunteers was completed and no remarkable adverse events were observed, even at the highest dose tested. After thorough analysis of the data, the study results were summarized in a Clinical Study Report which concluded that the drug was safe and well tolerated. These results served as the basis of the phase-1b clinical study plan. The clinical study plan has been approved by a central Institutional Review Board (IRB). This allows Nitto to initiate the phase-1b clinical study in subjects with moderate to severe liver fibrosis for the assessment of safety and efficacy of the drug. Following the start of the US study, Nitto will also conduct a clinical study in Japan. The clinical studies in the US have been conducted in collaboration with RRD International Inc.

Nitto Denko Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2014; Provides Second Quarter and Year End Dividend Guidance for the Year Ending March 31, 2015; Provides Consolidated Earnings Guidance for the First Half of the Fiscal 2015 and Full Year Ending March 31, 2014

Nitto Denko Corporation announced consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of JPY 185,910 million against JPY 179,255 million a year ago. Operating income was JPY 19,313 million against JPY 17,402 million a year ago. Ordinary income was JPY 19,207 million against JPY 17,259 million a year ago. Net income attributable to the owners of the parent company was JPY 12,064 million or JPY 72.98 per diluted share against JPY 11,294 million or JPY 68.33 per diluted share a year ago. Net cash provided by operating activities was JPY 28,212 million against JPY 9,136 million a year ago. Income before income taxes was JPY 7,101 million against JPY 5,870 million a year ago. Purchase of property, plant and equipment and intangible assets was JPY 11,153 million against JPY 14,484 million a year ago. For the year ending March 31, 2015, the company expects to pay a second quarter dividend of JPY 50.00 per share and a year end dividend of JPY 50.00 per share. For the first half of fiscal 2015, on consolidated basis, the company expects net sales of JPY 385,000 million, operating income of JPY 43,000 million, ordinary income of JPY 43,000 million and net income attributable to the owners of the company of JPY 30,000 million or JPY 181.87 per share. For the fiscal 2014, on consolidated basis, the company expects net sales of JPY 780,000 million, operating income of JPY 78,000 million, ordinary income of JPY 78,000 million and net income attributable to the owners of the company of JPY 57,000 million or JPY 345.56 per share.

Nitto Denko Corporation Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-08-2014

Nitto Denko Corporation Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-08-2014 . Venue: Grand Hyatt Tokyo, Tokyo, Japan.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6988:JP ¥5,461.00 JPY +120.00

6988 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Avery Dennison Corp $43.43 USD +0.30
Fujikura Ltd ¥456.00 JPY +15.00
Rogers Communications Inc C$43.67 CAD +1.39
TTM Technologies Inc $6.02 USD +0.06
Zhen Ding Technology Holding Ltd 79.70 TWD +4.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 6988 Industry Range
Price/Earnings 16.8x
Price/Sales 1.1x
Price/Book 1.6x
Price/Cash Flow 15.1x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NITTO DENKO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at